Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Denmark suspends use of AstraZeneca vaccine over blood clot fears

11th Mar 2021 10:07

(Alliance News) - Danish health authorities said Thursday they were temporarily suspending the use of AstraZeneca PLC's Covid-19 vaccine as a precaution after some patients developed blood clots since receiving the jab.

The move comes "following reports of serious cases of blood clots among people vaccinated with AstraZeneca's Covid-19 vaccine", the Danish Health Authority said in a statement. 

But it cautiously added that "it has not been determined, at the time being, that there is a link between the vaccine and the blood clots".

AstraZeneca shares were down 2.1% at 7,039.00 pence in London on Thursday morning.

source: AFP

Copyright 2021 Alliance News Limited. All Rights Reserved.


Related Shares:

Astrazeneca
FTSE 100 Latest
Value8,403.18
Change74.58